Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Alembic Bags USFDA Approval for USD 27 Million Lamotrigine ODT Market

Parthika Patel26 Feb 2026 10:14 PM IST

New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug...

Dr Reddy's Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: Report

Parthika Patel26 Feb 2026 10:01 PM IST

Mumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name...

Allahabad HC Denies Bail in Phensedyl Diversion Case, Accused Directed to Surrender

Parthika Patel26 Feb 2026 9:44 PM IST

Lucknow: The Allahabad High Court has refused to grant regular bail to two individuals accused in a case involving the alleged illegal storage and...

Aurobindo's Eugia Arm Secures USFDA Nod for Transplant Drug Everolimus

Parthika Patel26 Feb 2026 9:27 PM IST

New Delhi: Aurobindo Pharma Limited announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from...

Andhra Drug Inspector, Aide Caught Red-Handed Accepting Rs 20,000 Bribe

Parthika Patel25 Feb 2026 2:25 PM IST

New Delhi: The Anti-Corruption Bureau (ACB) arrested a Drug Inspector and his private aide in Andhra Pradesh after they were caught red-handed while...

Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in US

Parthika Patel25 Feb 2026 2:01 PM IST

Mumbai: Mumbai-based pharmaceutical major Lupin Limited has received approval from the US Food and Drug Administration (USFDA) for its Brivaracetam...

Chemist Killed in Reactor Explosion at Telangana Pharma Unit, Probe Underway

Parthika Patel25 Feb 2026 1:50 PM IST

New Delhi: A 35-year-old chemist died after a fire broke out following a reactor explosion at a pharmaceutical manufacturing unit in Telangana's...

Telangana DCA Raids Illegal Clinic in Hanumakonda, Seizes Antibiotics, Steroids, Tramadol

Parthika Patel24 Feb 2026 10:19 PM IST

New Delhi: The Drugs Control Administration (DCA), Telangana, raided an unqualified practitioner's clinic in Shayampet village of Hanumakonda district...

Medical Representative Held for Allegedly Murdering Pharma Marketing Manager in Odisha

Parthika Patel23 Feb 2026 11:30 PM IST

Bhubaneswar: A 23-year-old medical representative has been arrested for allegedly murdering a pharmaceutical company's marketing manager during a...

Cipla's Lanreotide Supply Partner's Greece Plant Gets USFDA OAI Status

Parthika Patel23 Feb 2026 11:13 PM IST

Mumbai: Cipla Limited has informed the stock exchanges that the US Food and Drug Administration (USFDA) has classified the recent current Good...

Morepen Labs Bags Rs 825 Crore Global CDMO Deal

Parthika Patel23 Feb 2026 11:02 PM IST

New Delhi: Morepen Laboratories Limited has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate worth...

Misuse of ORS Label: FSSAI Issues 75 Notices to FBOs for Non-WHO Compliant Drinks

Pharma Firm Issued Notice Over Alleged Supply of Questionable Anti-Snake Venom

Parthika Patel22 Feb 2026 2:45 PM IST

Panaji: Goa police have served a notice to a pharmaceutical company in connection with the alleged supply of questionable anti-snake venom to the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok